The Alpha IMS piece will benefit blind patients who lost their eyesight due to conditions such as retinitis pigmentosa. These patients still have their vision neurons in place, enabling the advanced tech tool to process light once implanted into the brain.
The Alpha IMS is different from its predecessors in that it does not use a camera to interpret signals. Instead, it is composed of a 15000 electrode grid. The grid sits beneath the retina, enabling patients to interpret their exterior environments via the eye's neurons. Clinical testing has revealed its efficacy, especially as it comes equipped with a dial along one's ear that allows for the personal adjustment of brightness and a pocket-based battery.
278 clicks in 60 w
More Stats +/-